Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms

The serum level of iron in humans is tightly controlled by the action of the hormone hepcidin on the iron efflux transporter ferroportin. Hepcidin regulates iron absorption and recycling by inducing the internalization and degradation of ferroportin 1 . Aberrant ferroportin activity can lead to dise...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 586; no. 7831; pp. 807 - 811
Main Authors Billesbølle, Christian B., Azumaya, Caleigh M., Kretsch, Rachael C., Powers, Alexander S., Gonen, Shane, Schneider, Simon, Arvedson, Tara, Dror, Ron O., Cheng, Yifan, Manglik, Aashish
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 29.10.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The serum level of iron in humans is tightly controlled by the action of the hormone hepcidin on the iron efflux transporter ferroportin. Hepcidin regulates iron absorption and recycling by inducing the internalization and degradation of ferroportin 1 . Aberrant ferroportin activity can lead to diseases of iron overload, such as haemochromatosis, or iron limitation anaemias 2 . Here we determine cryogenic electron microscopy structures of ferroportin in lipid nanodiscs, both in the apo state and in complex with hepcidin and the iron mimetic cobalt. These structures and accompanying molecular dynamics simulations identify two metal-binding sites within the N and C domains of ferroportin. Hepcidin binds ferroportin in an outward-open conformation and completely occludes the iron efflux pathway to inhibit transport. The carboxy terminus of hepcidin directly contacts the divalent metal in the ferroportin C domain. Hepcidin binding to ferroportin is coupled to iron binding, with an 80-fold increase in hepcidin affinity in the presence of iron. These results suggest a model for hepcidin regulation of ferroportin, in which only ferroportin molecules loaded with iron are targeted for degradation. More broadly, our structural and functional insights may enable more targeted manipulation of the hepcidin–ferroportin axis in disorders of iron homeostasis. Structures of the iron transporter ferroportin and the peptide hormone hepcidin suggest how iron homeostasis is tightly regulated.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author Contributions
C.B.B. purified FPN and Fab fragments, established biochemical approaches to reconstitute a ferroportin-hepcidin complex, established and performed hepcidin binding and calcein transport assays, prepared samples for cryo-EM, screened samples by negative stain and cryo-EM, and determined the X-ray crystal structure of Fab45D8. C.M.A. identified optimal freezing conditions for FPN samples, collected cryo-EM data, and determined high resolution cryo-EM maps by extensive image processing. R.C.K. and A.S.P. performed and analysed molecular dynamics simulations under the guidance of R.O.D. S.G. collected negative stain and cryo-EM data for FPN samples bound to different Fabs, and identified Fab45D8 as a fiducial marker for structure determination. S.S. aided in establishing and performing the calcein transport assay. T.A. provided fluorescently labeled hepcidin and anti-FPN antibodies for structure determination. A.M. built and refined models of FPN and Fab45D8. The manuscript was written by C.B.B., C.M.A., Y.C., and A.M. with revisions provided by all authors. The overall project was supervised by Y.C. and A.M.
ISSN:0028-0836
1476-4687
1476-4687
DOI:10.1038/s41586-020-2668-z